ERBB2 and breast carcinoma: In the study of breast cancer cells, the researchers found that activating Y153 phosphorylation through the HER2/ABL axis stabilizes other mitochondrial CK isozymes CKMT1, thereby increasing phosphocreatine energy shuttling and promoting proliferation32.